Philip Duong
Directeur/Membre du Conseil chez KAROLINSKA DEVELOPMENT AB
Provenance du réseau au premier degré de Philip Duong
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Deutsche Bank AG (Hong Kong)
 Deutsche Bank AG (Hong Kong) Investment Banks/BrokersFinance Part of Deutsche Bank AG, Deutsche Bank AG (Hong Kong) is a financial institution that has been connecting worlds for 65 years. The private company is based in Hong Kong, Hong Kong, and serves as the hub for corporate and commercial clients. The company's asset management division, DWS, is a market leader in Hong Kong with a broad product offering. Its corporate bank division is an established market leader in transaction banking, with a presence in 60 countries, including an extensive footprint in HK. The investment bank provides strategic advice to corporate and institutional clients, focusing on the bank’s traditional strengths in financing, advisory, fixed income, and currencies, together with a focused equity capital markets business. The private bank focuses on private customers across all segments as well as business clients, and in HK, this division is represented by a highly competitive wealth manager. The Chinese company was founded in 1958, and its CEO is Werner Steinmüller.
76
| Subsidiary | Investment Banks/Brokers | 76 |
| Public Company | Pharmaceuticals: Major | 22 | |
| Public Company | Financial Conglomerates | 14 | |
Treadwell Therapeutics, Inc.
 Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Softhale NV
 Softhale NV Miscellaneous Commercial ServicesCommercial Services Softhale NV engages in manufacturing medical, clinical and pharmaceutical equipment. The company was founded by Jurgen Rawert and Frank Bartels and is headquartered in Diepenbeek, Belgium.
4
| Subsidiary | Miscellaneous Commercial Services | 4 |
invoX Pharma Ltd.
 invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., invoX Pharma Ltd. is a British biopharmaceutical company. The private company is based in Kingston-upon-Thames, UK. The company was founded in 2021. Benjamin Toogood has been the CEO of the company since 2023.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Philip Duong via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
UBS Securities (Asia) Ltd.
 UBS Securities (Asia) Ltd. Investment Banks/BrokersFinance UBS Securities Asia Ltd. (UBS Asia) is a brokerage firm headquartered in Hong Kong. The firm is a subsidiary of UBS AG, which is owned by UBS Group AG (SWX: UBSG) in Switzerland. UBS Asia provides corporate and institutional clients which include intermediary and alternative asset managers with financial advisory services, access to the world's capital markets and securities products and research in the field of equity, fixed-income, rates, foreign exchange, energy and metals. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity Analyst-Equity Director of Research - Equity Analyst-Equity Corporate Officer/Principal Analyst-Equity | |
| Chia Tai-Tianqing Pharmaceutical Holdings Co., Ltd. | Director/Board Member Director/Board Member Corporate Officer/Principal President Director/Board Member | ||
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The private company was founded in 1969, and the CEO is Kang Xin Yu. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member Chairman | |
Beijing Tide Pharmaceutical Co., Ltd.
 Beijing Tide Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Beijing Tide Pharmaceutical Co., Ltd. engages in research, development, manufacturing and sale of pharmaceutical products. The firm's products include kaifen flurbiprofen axetil injection, kaishi alprostadil injection, kaina beraprost sodium tablet and deyou pronase granules. The company was founded in May 1995 and is headquartered in Beijing, China. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member | |
Jefferies Hong Kong Ltd.
 Jefferies Hong Kong Ltd. Investment Banks/BrokersFinance Jefferies Hong Kong Ltd. is a securities brokerage firm headquartered in Hong Kong. The firm is a subsidiary of Jefferies Group LLC, which is owned by Jefferies Financial Group, Inc. (NYSE: JEF) in the US. Jefferies Hong Kong is a client-focused full-service sales, trading and capital markets platform across all equity and fixed income securities. They provide an array of trading and execution services for their clients. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity Analyst-Equity Corporate Officer/Principal | |
Merrill Lynch Far East Ltd.
 Merrill Lynch Far East Ltd. Investment Banks/BrokersFinance Merrill Lynch Far East Ltd. is the stockbroking subsidiary of Merrill Lynch HK Services Ltd., ultimately owned by Bank of America Corp. (NYSE: BAC) in the US. Headquartered in Hong Kong, the firm was founded in 2003 and offers a broad range of brokerage services to institutional investors. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity Analyst-Equity | |
| Chia Tai Shaoyang Orthopedic Hospital | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | ||
Macquarie Capital Ltd.
 Macquarie Capital Ltd. Investment Banks/BrokersFinance Macquarie Capital Ltd. is the Hong Kong-based securities brokerage arm of Macquarie Group Ltd. (ASX: MQG), a global financial services group headquartered in Australia. Macquarie Capital offers brokerage services to various investors. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Economist | |
Tio Bioventures
 Tio Bioventures Investment ManagersFinance Tio Bioventures (Tio Bioventures) is a venture capital firm founded in 2019 by Tak Wah Mak and Shane Burgess. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Chief Executive Officer Private Equity Investor | |
| The Chinese University of Hong Kong | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Other Consumer Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
China International Capital Corp. Ltd. (Broker)
 China International Capital Corp. Ltd. (Broker) Investment Banks/BrokersFinance China International Capital Corp. Ltd. (Broker) (CICC) is the brokerage division of China International Capital Corp. Ltd. which was established in 1995 as a strategic partnership between Chinese and international financial institutions and corporations. Headquartered in Beijing, CICC was the first joint venture investment bank in China. The firm's core business departments were investment banking, capital markets, sales & trading, research, fixed-income and asset management. CICC offers a range of brokerage services to international and domestic institutional and individual investors. In 2007 the firm set up a wholly-owned subsidiary specializing in private equity investments and focusing on buyout opportunities within China. | Investment Banks/Brokers | Market Strategist Analyst-Equity Market Strategist | |
Citigroup Global Markets Asia Ltd.
 Citigroup Global Markets Asia Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Asia Ltd. (CGMA) is a securities brokerage firm headquartered Hong Kong. They are a subsidiary of Citigroup Global Markets Hong Kong Holdings Ltd., ultimately owned by Citigroup, Inc. (NYSE: C) in the US. Formerly known as Citi Smith Barney, the firm was reorganized in 2008 when Citigroup combined their brokerage and private banking businesses. CGMA offers stock trading services to various institutional investors. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member | |
AnaCardio AB
 AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
Cp Pharmaceutical Qingdao Co. Ltd.
 Cp Pharmaceutical Qingdao Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Cp Pharmaceutical Qingdao Co. Ltd. is a private company that engages in the research and development, production, and sale of osteoporosis medicines and marine pharmaceuticals. Cp Pharmaceutical Qingdao Co. Ltd. is based in Qingdao, China. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
UBS Securities Co. Ltd.
 UBS Securities Co. Ltd. Investment Banks/BrokersFinance UBS Securities Co. Ltd. is the Chinese brokerage subsidiary of UBS Group AG (SWX: UBSG) in Switzerland. Headquartered in Beijing, the firm was founded in 2006 as Beijing Securities Co. Ltd. They provide securities brokerage services to domestic corporate and institutional clients, and qualified foreign institutional investors (QFII). | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity | |
| University of Lund | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Director/Board Member Director/Board Member Corporate Officer/Principal | ||
| Chia Tai Yeheng Biotech (Shanghai) Co., Ltd. | Director/Board Member Director/Board Member | ||
| Deutsche Securities Asia Ltd. (Taiwan) | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Svenska Vaccinfabriken Produktion AB
 Svenska Vaccinfabriken Produktion AB BiotechnologyHealth Technology Svenska Vaccinfabriken Produktion AB develops vaccines and immunotherapies to prevent and treat life-threatening diseases. The company is based in Stockholm, Sweden. The Swedish company was founded by Matti Sällberg, Margaret Chen, Jens Bäck, Lars Frelin. Richard Bethell has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
| DEUTSCHE BANK AG | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
| CP Boai Investment Ltd. | Director/Board Member Director/Board Member | ||
Nomura International (Hong Kong) Ltd.
 Nomura International (Hong Kong) Ltd. Investment Banks/BrokersFinance Nomura International (Hong Kong) Ltd. (Nomura International HK) is the brokerage subsidiary of Nomura Asia Pacific Holdings Co. Ltd., which is ultimately-owned by Nomura Holdings, Inc. (TYO: 8604) in Japan. Headquartered in Hong Kong, the firm’s global markets team offers research, sales and trading of global securities to a diverse range of clients globally, including institutional investors, financial institutions, corporates, financial sponsors and government entities. Nomura International HK operates a truly integrated, cross-asset platform which includes research, sales and trading in equities, currencies, rates and credit in cash and derivative products. | Investment Banks/Brokers | Director/Board Member Analyst-Equity | |
| SCIBASE HOLDING AB (PUBL) | Medical Specialties | Director/Board Member Director/Board Member | |
Credit Suisse (Hong Kong) Ltd.
 Credit Suisse (Hong Kong) Ltd. Investment Banks/BrokersFinance Credit Suisse (Hong Kong) Ltd. (CSHK) is a securities brokerage firm headquartered Hong Kong. The firm is a subsidiary of Credit Suisse AG, which is owned by Credit Suisse Group AG (SWX: CSGN; ADR: CS) in Switzerland. CSHK provides corporate and institutional investors with sales, trading, financing, prime services, and market-making in global equities, as well as equities-related securities, options, futures, risk management, and hedging products. Their client-focused platform offers issuer and investor clients access to distribution, trading, and origination capabilities across various markets globally. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
The Hongkong & Shanghai Banking Corp. Ltd. (Broker)
 The Hongkong & Shanghai Banking Corp. Ltd. (Broker) Investment Banks/BrokersFinance The Hongkong & Shanghai Banking Corp. Ltd. (Broker) (HSBC-Broker) is the brokerage division of The Hongkong & Shanghai Banking Corp. Ltd. in Hong Kong. Their ultimate parent is HSBC Holdings Plc (LON: HSBA), a multinational investment bank and financial services holding company headquartered in London, UK. HSBC-Broker provides securities brokerage services to their clients. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| KD Incentive AB | Director/Board Member Director/Board Member | ||
| Guanghua School of Management | College/University | Masters Business Admin Corporate Officer/Principal | |
| Scibase AB | Director/Board Member Director/Board Member | ||
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chief Executive Officer Director of Finance/CFO | |
| OSSDSIGN AB | Medical Specialties | Director/Board Member Director/Board Member | |
| MODUS THERAPEUTICS HOLDING AB | Biotechnology | Chairman Chief Executive Officer | |
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Chairman Director/Board Member | |
Dilafor AB
 Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| PROMIMIC AB | Medical Specialties | Corporate Officer/Principal Director/Board Member | |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Friends of Hong Kong Association Ltd. | Corporate Officer/Principal Chief Executive Officer | ||
| University of Hong Kong | College/University | Undergraduate Degree Undergraduate Degree | |
Sino Biopharmaceutical (Beijing) Ltd.
 Sino Biopharmaceutical (Beijing) Ltd. Miscellaneous Commercial ServicesCommercial Services Sino Biopharmaceutical (Beijing) Ltd. is an investment holding company. Its sole asset is its 33.6% interest in Beijing Tide Pharmaceutical Co., Ltd., a pharmaceutical company established in China with limited liability, which develops, manufactures, and market pharmaceutical products. Sino Biopharmaceutical (Beijing) was founded on December 31, 2007 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Qingdao Chia Tai Haier Pharmaceutical Co. Ltd.
 Qingdao Chia Tai Haier Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Qingdao Chia Tai Haier Pharmaceutical Co. Ltd. manufactures and sells pharmaceuticals. It is a subsidiary of Chia Tai Wing Fuk Ltd. It is headquartered in Qingdao, China | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TIANJIN BINHAI TEDA LOGISTICS (GROUP) CORPORATION LIMITED | Air Freight/Couriers | Director/Board Member Director/Board Member | |
| Nanjing Medical University | College/University | Doctorate Degree Doctorate Degree | |
| Xian CP Pharmaceutical Co. Ltd. | Chairman Chief Executive Officer | ||
Hong Kong Institute of Certified Public Accountants
 Hong Kong Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Hong Kong Institute of Certified Public Accountants operates under the professional accountant’s ordinance and works in the public interest. It offers CPA qualification programme and promulgating financial reporting, auditing and ethical standards in Hong Kong. The company was founded on January 1, 1973 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Beijing Chia Tai Green Continent Pharmaceutical Co. Ltd.
 Beijing Chia Tai Green Continent Pharmaceutical Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Sino Biopharmaceutical Ltd., Beijing Chia Tai Green Continent Pharmaceutical Co. Ltd. researches and produces new pharmaceutical products. The private company is based in Beijing, China. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member |
Statistiques
Internationale
| Hong Kong | 16 |
| Chine | 16 |
| Suède | 16 |
| Etats-Unis | 4 |
| Taïwan | 2 |
Sectorielle
| Finance | 15 |
| Health Technology | 13 |
| Consumer Services | 8 |
| Commercial Services | 7 |
| Transportation | 2 |
Opérationnelle
| Director/Board Member | 233 |
| Corporate Officer/Principal | 105 |
| Analyst-Equity | 102 |
| Independent Dir/Board Member | 43 |
| Chairman | 34 |
Relations les plus connectées
| Insiders | |
|---|---|
| Ping Tse | 43 |
| Viktor Drvota | 41 |
| Per Gunnar Ernst Aniansson | 31 |
| Zheng Fei Lu | 27 |
| Anna Lefevre Skjöldebrand | 17 |
| Kwok Tung Li | 17 |
| Cheung Ling Cheng | 15 |
| Hsin Tse | 15 |
| Björn Cochlovius | 14 |
| Theresa Tse | 14 |
| Greg Parekh | 14 |
| Jiong Shao | 12 |
| John Öhd | 11 |
| Johan Dighed | 10 |
| Thomas Andersson | 10 |
- Bourse
- Insiders
- Philip Duong
- Connexions Sociétés
